493 related articles for article (PubMed ID: 9234798)
21. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
Pal S; Peterson EM; de la Maza LM
Vaccine; 2005 Nov; 23(46-47):5351-8. PubMed ID: 16085340
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.
Ralli-Jain P; Tifrea D; Cheng C; Pal S; de la Maza LM
Vaccine; 2010 Nov; 28(48):7659-66. PubMed ID: 20875490
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
24. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.
Dong-Ji Z; Yang X; Shen C; Lu H; Murdin A; Brunham RC
Infect Immun; 2000 Jun; 68(6):3074-8. PubMed ID: 10816446
[TBL] [Abstract][Full Text] [Related]
25. Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine.
Tifrea DF; Sun G; Pal S; Zardeneta G; Cocco MJ; Popot JL; de la Maza LM
Vaccine; 2011 Jun; 29(28):4623-31. PubMed ID: 21550371
[TBL] [Abstract][Full Text] [Related]
26. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
Pal S; Tifrea DF; Follmann F; Andersen P; de la Maza LM
Vaccine; 2017 Mar; 35(13):1705-1711. PubMed ID: 28238632
[TBL] [Abstract][Full Text] [Related]
27. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice.
Pal S; Peterson EM; de la Maza LM
Immunology; 2003 Nov; 110(3):368-75. PubMed ID: 14632665
[TBL] [Abstract][Full Text] [Related]
28. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
29. A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
Cheng C; Jain P; Bettahi I; Pal S; Tifrea D; de la Maza LM
Vaccine; 2011 Sep; 29(38):6641-9. PubMed ID: 21742006
[TBL] [Abstract][Full Text] [Related]
30. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.
Cheng C; Bettahi I; Cruz-Fisher MI; Pal S; Jain P; Jia Z; Holmgren J; Harandi AM; de la Maza LM
Vaccine; 2009 Oct; 27(44):6239-46. PubMed ID: 19686693
[TBL] [Abstract][Full Text] [Related]
31. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa.
Schautteet K; Stuyven E; Beeckman DS; Van Acker S; Carlon M; Chiers K; Cox E; Vanrompay D
Vaccine; 2011 Feb; 29(7):1399-407. PubMed ID: 21195805
[TBL] [Abstract][Full Text] [Related]
32. A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility.
Tifrea DF; Pal S; de la Maza LM
J Infect Dis; 2020 Jan; 221(2):191-200. PubMed ID: 31504647
[TBL] [Abstract][Full Text] [Related]
33. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
Pal S; Bravo J; Peterson EM; de la Maza LM
Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
[TBL] [Abstract][Full Text] [Related]
34. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.
Berry LJ; Hickey DK; Skelding KA; Bao S; Rendina AM; Hansbro PM; Gockel CM; Beagley KW
Infect Immun; 2004 Feb; 72(2):1019-28. PubMed ID: 14742549
[TBL] [Abstract][Full Text] [Related]
35. A new murine model for testing vaccines against genital Chlamydia trachomatis infections in males.
Pal S; Sarcon AK; de la Maza LM
Vaccine; 2010 Nov; 28(48):7606-12. PubMed ID: 20920574
[TBL] [Abstract][Full Text] [Related]
36. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
[TBL] [Abstract][Full Text] [Related]
37. Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis.
Motin VL; de la Maza LM; Peterson EM
Clin Diagn Lab Immunol; 1999 May; 6(3):356-63. PubMed ID: 10225836
[TBL] [Abstract][Full Text] [Related]
38. Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.
Carmichael JR; Pal S; Tifrea D; de la Maza LM
Vaccine; 2011 Jul; 29(32):5276-83. PubMed ID: 21609745
[TBL] [Abstract][Full Text] [Related]
39. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.
Tu J; Hou B; Wang B; Lin X; Gong W; Dong H; Zhu S; Chen S; Xue X; Zhao KN; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2014 May; 46(5):401-8. PubMed ID: 24681882
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine.
Yu H; Karunakaran KP; Jiang X; Chan Q; Rose C; Foster LJ; Johnson RM; Brunham RC
Vaccine; 2020 Apr; 38(16):3280-3291. PubMed ID: 32151463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
